pharmaphorum

NOVEMBER 7, 2022

As we continue to enter new markets, grow within our existing markets and reach a broader population, we continue to invest in our operations, talent and technology capabilities to support that growth.” ” Jill Howe, Lineage Cell Therapeutics. ” Patrick Genestin, 1910 Genetics .

Management 91

Management Pharmaceutical Pharma Marketing 91

Impetus Digital

MARCH 15, 2024

A version of this article was previously published in the Journal of mHealth. In 2022, global spending on cancer medicines was approximately 196 billion USD, and this number is forecasted to reach $375 billion by 2027. However, these technologies will not be suitable for all studies and all patient populations.

Recruitment 83

Recruitment Healthcare Provider Patients Healthcare 83

PM360

AUGUST 24, 2023

Now, Real Chemistry is at the forefront of applying analytics, data, and artificial intelligence to the biopharma and healthcare industry and, in 2022, the company achieved its 21st consecutive year of double-digit growth. Profiles of all of the winners will be included in PM360’s November issue.

Marketing 52

Marketing Education Media Healthcare 52

PM360

OCTOBER 5, 2023

Now, Real Chemistry is at the forefront of applying analytics, data, and artificial intelligence to the biopharma and healthcare industry and, in 2022, the company achieved its 21st consecutive year of double-digit growth. PM360 will publish profiles of this year’s Trailblazer winners in its November issue and on its website.

Education 52

Education Marketing Media Biopharma 52

Pharmaceutical Technology

NOVEMBER 15, 2022

However, a recent study in the Journal of American Medical Association suggests that Paxlovid may not be the sole cause for this relapse in Covid-19 symptoms. In the recent JAMA publication, Covid-19 symptoms were assessed for 29 days in untreated participants who received a placebo in the ACTIV-2/A5401 trial between August and November 2020.

Food and Drug Administration 64

Food and Drug Administration Government Distribution FDA 64

European Pharmaceutical Review

NOVEMBER 11, 2022

The American Heart Association (AHA)’s Scientific Sessions 2022 is a global exchange of the latest advancements in research and clinical practice of cardiovascular science. Heart failure treated with first-in-human in vivo gene-editing therapy using CRISPR technology . Baxdrostat – treating hypertension drug-resistance.

Safety 100

Safety Medical Patients Transportation 100